HARTFORD, Conn.— reSET, the Social Enterprise Trust, today announced that Amy Fry has been elected to its Board of Directors.

Fry has been with Boehringer Ingelheim Pharmaceuticals, Inc. (BI) since 2004 as Vice President of Public Affairs and Communications. She has over twenty-five years of professional experience with an emphasis in organizational transformation and effectiveness, public relations, employee engagement, change management and marketing communications. She also has experience in government affairs, patient advocacy and professional relations.

Additionally, Fry serves on the board of the Boehringer Ingelheim Cares Foundation, and leads BI’s Making More Health global imitative to create social business solutions to improve health for undeserved patients. She has been recognized for her ability to lead change, drive organizational effectiveness, and influence outcomes through relationships and across boundaries.

BI is the world’s largest independently-owned pharmaceutical company. Since 2011, the company has supported reSET’s Social Enterprise Awards with the Boehringer Ingelheim More Health Through Innovation award. This award is given annually to a Connecticut-based social entrepreneur who is building a business that aims to improve the health of individuals and communities.

reSET is pleased to welcome Amy Fry to it’s Board of Directors.

About reSET

The Social Enterprise Trust, commonly known as reSET, is a Hartford-based nonprofit organization whose mission is to promote, preserve and protect social enterprise as a viable concept and a business reality. reSET’s strategic goal is to make Connecticut the social enterprise state.

reSET offers advice and mentoring through an Entrepreneur-in-Residence and a Business Advisor Network, the Lean LaunchPad for Impact program for entrepreneurs to test their business concepts, technical workshops, Design Labs, and community programs and resources. reSET also sponsors the annual Social Enterprise Challenge and Awards.